文献速递消化系统肿瘤

色氨酸2,3-双加氧酶2在APC突变结直肠癌中的合成致死性

Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer.
PubMed 文献 · Cancer Discov · 2022-01-01

该研究将合成致死性框架应用于APC缺陷型癌症,鉴定出色氨酸2,3-双加氧酶2(TDO2)为APC缺陷型结直肠癌的合成致死效应因子。机制上APC缺陷经TCF4/β-catenin上调TDO2转录,TDO2激活Kyn-AhR通路,增强糖酵解并分泌CXCL5招募巨噬细胞。APC缺陷型结直肠癌模型对TDO2缺失或药理抑制敏感。

要点

  • APC缺陷经TCF4/β-catenin介导上调TDO2基因转录。
  • TDO2激活Kyn-AhR通路,增强糖酵解并促CXCL5分泌招募巨噬细胞。
  • APC缺陷型结直肠癌模型对TDO2缺失或药理抑制敏感,增殖受损、抗肿瘤免疫特征增强。

核心结论

  • APC缺陷激活TCF4-TDO2-AhR-CXCL5回路,经自主与非自主机制影响多个癌症标志,揭示结直肠癌的基因型特异性易感性。
  • 本研究确定了APC缺陷型结直肠癌维持的关键效应因子,并阐明APC/WNT通路与犬尿氨酸通路信号的关系。
  • 研究进一步确定了APC缺陷型结直肠癌中肿瘤相关巨噬细胞的生物学,为基因型特异性治疗靶点及TDO2抑制剂的使用提供信息。

研究设计与样本

  • 研究应用合成致死性框架,以鉴定APC缺陷型癌症的可成药脆弱点。
  • TDO2被鉴定为APC缺陷型结直肠癌的合成致死效应因子。

主要发现

  • APC缺陷导致TCF4/β-catenin介导的TDO2基因转录上调。
  • TDO2激活Kyn-AhR通路,增加糖酵解以驱动癌症细胞合成代谢性生长,并增加CXCL5分泌以招募巨噬细胞进入肿瘤微环境。
  • APC缺陷型结直肠癌模型对TDO2缺失或药理抑制敏感,癌症细胞增殖受损、抗肿瘤免疫特征增强。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Inactivation of adenomatous polyposis coli (APC) is common across many cancer types and serves as a critical initiating event in most sporadic colorectal cancers. APC deficiency activates WNT signaling, which remains an elusive target for cancer therapy, prompting us to apply the synthetic essentiality framework to identify druggable vulnerabilities for APC-deficient cancers. Tryptophan 2,3-dioxygenase 2 (TDO2) was identified as a synthetic essential effector of APC-deficient colorectal cancer. Mechanistically, APC deficiency results in the TCF4/β-catenin-mediated upregulation of TDO2 gene transcription. TDO2 in turn activates the Kyn-AhR pathway, which increases glycolysis to drive anabolic cancer cell growth and CXCL5 secretion to recruit macrophages into the tumor microenvironment. Therapeutically, APC-deficient colorectal cancer models were susceptible to TDO2 depletion or pharmacologic inhibition, which impaired cancer cell proliferation and enhanced antitumor immune profiles. Thus, APC deficiency activates a TCF4-TDO2-AhR-CXCL5 circuit that affects multiple cancer hallmarks via autonomous and nonautonomous mechanisms and illuminates a genotype-specific vulnerability in colorectal cancer. SIGNIFICANCE: This study identifies critical effectors in the maintenance of APC-deficient colorectal cancer and demonstrates the relationship between APC/WNT pathway and kynurenine pathway signaling. It further determines the tumor-associated macrophage biology in APC-deficient colorectal cancer, informing genotype-specific therapeutic targets and the use of TDO2 inhibitors. This article is highlighted in the In This Issue feature, p. 1599.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Lee R, Li J, Li J, et al. Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer. Cancer Discov. 2022. PMID: 35537038. doi:10.1158/2159-8290.CD-21-0680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。